NHS moves a step ahead towards its efforts to address covid-19 backlogs by opening a new 'planned care' hospital in Berkshire dedicated to non-emergency treatment.
Heatherwood Hospital in Ascot, part of Frimley Health NHS Foundation Trust, will focus on cutting waits for routine care with staff prioritising patients who have been waiting longest, including for orthopaedic and ophthalmology services.
The hospital houses six operating theatres, 48 inpatient beds and 22 day-case cubicles and provides surgical, diagnostic and outpatient care, and will treat patients
across Berkshire, Hampshire and Surrey.
There will also be a range of outpatient services under the same roof including gynaecology, urology and cardiology services. These will be supported by services
offering patients endoscopy, physiotherapy, phlebotomy and radiology checks and treatments.
A Labour Party analysis of NHS trust figures has revealed that around 148,000 people died last year while waiting for treatment in England.
This is more than double the figure recorded in 2017/18, which stood at around 60,000 deaths. It even surpasses the mortality rate observed in 2021, during
the peak of the Covid pandemic.
The Labour Party obtained the data through a freedom of information request sent to every NHS trust in England. Out of the 169 acute and community trusts
contacted, 80 responded.
The total number of deaths reported by the respondents was 61,396. Extrapolating this figure to all trusts would suggest a total of 148,227 deaths.
To support NHS, clear the backlog created by the Covid-19 pandemic and help community pharmacies support more people, the Welsh government has announced an allocation of further £12.5 million funding.
Of the total amount, £10mn will be distributed across the 22 local authorities to buy equipment to help people to live independently in their own homes post hospital stay.
The remainder, £2.5mn, will be used to support community pharmacists and patients to improve access to treatment and advice for a range of common ailments.
The move is aimed at alleviating waiting times and reducing winter pressures on the NHS.
Commenting on the announcement, Elen Jones, Royal Pharmaceutical Society director for Wales said: "We are delighted that the Welsh government continue to recognise the value of pharmacists in patient care and we welcome this additional investment and support for Community Pharmacy teams across Wales.
Boris Johnson has picked Steve Barclay as the new health secretary following the resignation of Sajid Javid, who stepped down on July 5 after saying he had
lost faith in prime minister's leadership.
Barclay - who had served as chief of staff of the prime minister since February 2022 - was previously a junior health minister in 2018, responsible for NHS workforce
and finance, before serving as Brexit secretary, chief secretary to the Treasury, and chancellor of the duchy.
He is the fourth health secretary after Jeremy Hunt, Matt Hancock and Sajid Javid in the past five years.
In a statement on his appointment, Barclay said it was "an honour" to be take up the position, adding: "Our NHS and social care staff have showed us time and again -
throughout the pandemic and beyond - what it means to work with compassion and dedication to transform lives.
"This government is investing more than ever before in our NHS and care services to beat the Covid-19 backlogs, recruit 50,000 more nurses, reform social care and
ensure patients across the country can access the care they need."
Over the past two years, the Covid pandemic has resulted in a backlog of elective care within the NHS, with record numbers of patients on waiting lists
across the UK. Despite efforts to catch up after the first wave, subsequent waves have put further strain on an already stretched NHS system.
This has had a tremendous impact on many patients waiting for routine dermatology appointments and, while every effort has been made to see patients with suspected
serious skin cancers within two weeks, this target is not always achieved.
With rising waiting times, pharmacists are increasingly the first port of call for patients suffering with a broad range of skin problems. From acne and rosacea,
eczema or psoriasis, to changing skin lesions or simple insect bites, pharmacists can give helpful advice, allowing some customers to find quick relief to their
skin complaint in mild cases, while directing others to see their GP without delay.
Below is some practical advice that pharmacists can give to their customers with commonly encountered skin complaints.
Acne
Acne is a common skin condition that not only affects teenagers but adults too. It is estimated that up to 40 per cent of women continue to suffer with acne into
their adult years. Acne has been linked to an increased incidence of depression, anxiety and even suicidal ideation.
Patients have reported feeling overlooked and often dismissed in their concerns by health care professionals.
Unfortunately, these issues have been further compounded by delays in being seen and treated due to the ongoing Covid pandemic. Pharmacists are well placed to help
acne patients choose the right skincare. This should consist of lightweight products, such as gel or milky cleansers, with moisturisers in serum, lotion or light
cream preparations. Some acne suitable products are further labelled as non-comedogenic.
Oil-based or occlusive preparations are best avoided. There are many good quality, non-comedogenic sun blocks suited
The All-Party Parliamentary Group (APPG) on Pharmacy published a new report on Monday (January 23) that calls for "urgent action" to relieve funding pressure
so there are "opportunities" for community pharmacy teams to deliver even more for their patients.
The report highlights the need for a new "strategic vision" for pharmacy and highlights opportunities for the network to be empowered to deliver even more for
patients.
However, the manifesto also underlines that there are the very real risks that this opportunity may be lost if significant and ongoing pressures are not addressed.
The recommendations are based on written and oral evidence gathered from frontline pharmacists, GPs, professional bodies and healthcare experts.
To harness the potential of pharmacy, the report recommends the Government must take urgent action to relieve the funding pressures on the community pharmacy sector
in the short term and review the long-term funding model for pharmacy.
It also suggested the Government must harness the power of pharmacy to help the NHS deal with the COVID-19 backlog and the UK's growing healthcare challenges.
It further recommended that future commissioning and funding must recognise that community pharmacy is the front door to the NHS for many patients.
Two dozen parliamentarians from across the political spectrum have called on the prime minister to act as a wave of pharmacy closures in recent years has
threatened to spiral out of control.
A letter to the prime minister signed by 24 MPs and peers has warned that worse could be yet to come after "spiralling business costs" and "year after year of real
terms funding cuts" have led to hundreds of pharmacy closures.
New data from the PSNC shows that over 639 local pharmacies have been lost in England since 2016.
"This is the equivalent to just short of one pharmacy closure per constituency", the cross-party group warned.
The letter comes as MPs came together at a parliamentary summit to call for pharmacies to be embraced as a "game-changer" for tackling healthcare backlogs and taking
pressure off other areas of the NHS. A 'Future of Pharmacy' event was attended by 53 parliamentarians on July 5 in the Palace of Westminster.
At the event parliamentarians heard directly from frontline pharmacists and representatives of pharmacy bodies where a map of constituency-specific pharmacy numbers
was also unveiled, with details of the number of pharmacy closures in MPs' local area.